MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 195 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $773,550 | -7.3% | 77,355 | +15.2% | 0.00% | – |
| Q2 2023 | $834,820 | +26.8% | 67,162 | -53.6% | 0.00% | – |
| Q1 2023 | $658,499 | +62.4% | 144,656 | +410.7% | 0.00% | – |
| Q4 2022 | $405,359 | -53.7% | 28,327 | -17.5% | 0.00% | -100.0% |
| Q3 2022 | $876,000 | -36.9% | 34,329 | -29.7% | 0.00% | 0.0% |
| Q2 2022 | $1,388,000 | +49.1% | 48,855 | +85.2% | 0.00% | – |
| Q1 2022 | $931,000 | -12.1% | 26,383 | +4.4% | 0.00% | -100.0% |
| Q4 2021 | $1,059,000 | +43.1% | 25,276 | +67.7% | 0.00% | – |
| Q3 2021 | $740,000 | +27.6% | 15,068 | +8.5% | 0.00% | – |
| Q2 2021 | $580,000 | +73.7% | 13,891 | +48.2% | 0.00% | – |
| Q1 2021 | $334,000 | +44.0% | 9,372 | +13.4% | 0.00% | – |
| Q4 2020 | $232,000 | – | 8,261 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |